Search

Your search keyword '"Battezzati, P."' showing total 39 results

Search Constraints

Start Over You searched for: Author "Battezzati, P." Remove constraint Author: "Battezzati, P." Publication Type Electronic Resources Remove constraint Publication Type: Electronic Resources
39 results on '"Battezzati, P."'

Search Results

1. Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival

2. Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe

3. Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls

4. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055))

5. Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool

6. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

7. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

8. Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis

9. Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis

10. Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population

11. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

12. Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

13. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

14. Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis

15. Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase

16. Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis

17. Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on alkaline phosphatase

18. The impact of geographical region on outcomes of patients with primary biliary cholangitis from western Europe

19. Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on the alkaline phosphatase

20. Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis

21. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

22. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

23. Collecting stories of illness experience: an undergraduate medical curriculum to develop connectedness and togetherness with patients

24. Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history

25. Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis: Risk factors and time trends in incidence and outcome

26. Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy

27. Learning to grasp the emotional dimensions of clinical practice and their powerful meaning. A study on how medical students’ report patients’ grief in their reflective writings

28. Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: A multicentre international study

30. Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis

31. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

32. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

34. Development and Validation of a Scoring System to Predict Outcomes of Patients with Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

35. Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: An international follow-up study

36. Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis

37. Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants.

38. Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: A multicenter study of 664 patients and 1992 healthy controls

39. Liver and biliary problems in cystic fibrosis

Catalog

Books, media, physical & digital resources